Profile picture

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Membership: FESC Member HFA Member
Follow
Biography
John Cleland is Emeritus Professor at the University of Glasgow in the United Kingdom. His main interest is heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines. Particular current interests include myocardial substrate, congestion & inflammation, telemonitoring & theranostics. He qualified from Glasgow in 1977, completed training at St. Mary's & Hammersmith Hospitals (London) and was subsequently awarded a British Heart Foundation Senior Fellowship in Glasgow. He was appointed Professor of Cardiology at University of Hull 1999-2013 and the National Heart & Lung Institute, Imperial College London 2013-18. He returned to Glasgow as Director of the Robertson Centre for Biostatistics & Clinical Trials 2016-2022 and subsequently (until 2026) as Professor of Cardiology. He founded the European Journal of Heart Failure. He helped found and was Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure
Logo ESC

Contributor content

Debate: what is heart failure with preserved ejection fraction?
Session
Debate: what is heart failure with preserved ejection fraction?
10 May 2026
Congestion and volume status in heart failure
Session
Congestion and volume status in heart failure
10 May 2026
Heart failure and comorbidities: navigating complex interactions
Session
Heart failure and comorbidities: navigating complex interactions
9 May 2026
Ask the Trialists - REBOOT-CNIC
Session
Ask the Trialists - REBOOT-CNIC
30 August 2025
Ask the Trialists - BETAMI-DANBLOCK
Session
Ask the Trialists - BETAMI-DANBLOCK
30 August 2025
Guideline-directed medical therapy implementation in special clinical scenarios
Session
Guideline-directed medical therapy implementation in special clinical scenarios
17 May 2025
Interventions for arrhythmia through the heart failure lens
Session
Interventions for arrhythmia through the heart failure lens
1 September 2024
Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?
Session
Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?
12 May 2024
Late-breaking science on risk in special populations
Session
Late-breaking science on risk in special populations
25 August 2023
IV iron: the story so far
Session
IV iron: the story so far
21 May 2023

ESC 365 is supported by